The DCAT Research & Benchmarking Task Force will be conducting its third benchmarking, Examining Current and Future Alignment of the Pharma Customer-Supplier Relationship, via online survey from July to August 2018. This survey will seek to independently illuminate what the critical interface areas are for each of the respective industries and highlight areas of alignment and misalignment and identify opportunities for improvement.
The results of this study will be released later this fall, and DCAT will hold a webinar for our member companies to highlight the results. Stay tuned!
Released in November, 2017, Value Based Metrics examined the practices and key metrics used by both pharmaceutical companies and suppliers to measure the benefits of value-creation activities in the supply of direct materials used in pharmaceutical/biopharmaceutical development and manufacturing.
Released in April, 2016, Value Creation in Pharmaceutical Procurement examined Procurement’s involvement in value creation, including its level of vertical and horizontal alignment and influence with its internal customers (senior executive management and business units) as well as with its suppliers for achieving corporate and business goals.
With 47 benchmarks assessed, this report serves as an important way to evaluate how your company stands with your peers in the industry.
Download value creation in pharmaceutical procurement
DCAT Benchmarking is a complimentary service for DCAT member companies. To access the study, you must be logged-in to DCAT Connect. Trouble logging in? Contact Erin Sanders at firstname.lastname@example.org or +1-609-208-1888 ext. 7001.
About DCAT Benchmarking
DCAT Benchmarking is a member service delivering in-depth studies examining the crucial issues impacting the pharmaceutical manufacturing value chain. It is a valuable way for learning of best practices and key metrics for companies engaged in pharmaceutical development and manufacturing.
DCAT Benchmarking studies are developed by the DCAT Research & Benchmarking Task Force, composed of member representatives from diverse industry backgrounds and company experience, to identify the topics of greatest interest for DCAT member companies.
Using objective research methods, DCAT Benchmarking studies provide targeted insight for companies engaged in pharmaceutical development and manufacturing in key functional areas, including sourcing, procurement, supply management, and project management.
Have suggestions for future benchmarking studies? Contact DCAT’s Editorial Director and Staff Liaison for the Research & Benchmarking Task Force, Patricia Van Arnum at email@example.com.
The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing.